Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Reuters Business Insights was a prominent provider of strategic market intelligence and business analysis reports, specializing in the pharmaceutical, biotechnology, and healthcare sectors. The company was widely recognized for its in-depth research series that detailed market trends, competitive landscapes, and regulatory shifts for global life science executives. While it operated under the Reuters brand through a strategic partnership, the entity was primarily driven by Business Insights Ltd, providing granular data on therapeutic area developments and corporate strategies. Its extensive portfolio covered critical industry topics such as drug delivery innovation, generic competition, and market sizing for emerging modalities. Following a period of industry consolidation, the company's intellectual property and research archives were integrated into larger business information groups, including Informa and GlobalData.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Reuters Business Insights.